Monday, July 15



Trulicity is a drug that is mostly administered to treat type 2 diabetes. It is also referred to by its generic name, dulaglutide. Trulicity is an injectable medication that is produced by Eli Lilly and is given once a week. It replicates the actions of a hormone called GLP-1 (glucagon-like peptide 1), which causes the liver to secrete less glucagon and more insulin. Although the U.S. Food and Drug Administration (FDA) has not authorized trulicity for weight reduction, it is occasionally administered off-label for weight control.

Read More: Trulicity lawsuit


Trulicity may have potential adverse effects, just like any other medicine. Side effects of Trulicity that are often reported include nausea, retching, diarrhea, and frequent bowel movements. In most cases, these symptoms are minor and transient. But it’s important to remember that Trulicity is a member of the GLP-1 receptor agonist medication family, which has been linked to more serious gastrointestinal side effects.

Gastroparesis and Trulicity

Delay in emptying the stomach causes symptoms including bloating, nausea, and vomiting, which is known as gastroparesis. Numerous things, such as diabetes, certain drugs, and neurological conditions, might contribute to it. There have been other instances recently of people who took Trulicity and suffered gastroparesis; these people need lengthy hospital stays in the emergency department. A prescription drug called Trulicity is used to treat type 2 diabetes by enhancing blood sugar regulation. Although the precise connection between Trulicity and the onset of gastroparesis is not entirely established, patients and healthcare professionals should be aware of this potentially serious and excruciating side effect.

Trulicity is a member of the group of drugs known as agonists of the glucagon-like peptide-1 receptor (GLP-1 RAs). These drugs function by slowing down digestion, lowering glucagon synthesis, and raising insulin secretion. Although they are usually well tolerated, Trulicity users are reporting an increasing number of incidents of gastroparesis.

It’s unclear exactly how exactly trulicity causes or contributes to the development of gastroparesis. The way the medicine affects stomach emptying and digestion might be a factor. Furthermore, individual variables including concurrent use of other drugs or pre-existing gastrointestinal disorders may also play a role in the development of gastroparesis in Trulicity users.

It’s crucial that patients contact their doctor right away if they have signs of gastroparesis after taking Trulicity. Gastroparesis can cause bloating, nausea, vomiting, stomach discomfort, and a sudden sense of fullness after eating. Some of the people who took Trulicity and then acquired gastroparesis report that it is a really unpleasant experience. In order to ascertain if the symptoms are indeed associated with the drug or whether there are other underlying reasons causing the development of gastroparesis, a comprehensive assessment is necessary.

When Trulicity is thought to be the cause of gastroparesis, medical professionals may think about stopping the drug and looking into other diabetes management strategies. It is crucial that patients inform their healthcare practitioner of any changes in their symptoms so that the right therapy modifications may be made.

In conclusion, despite the fact that Trulicity is usually well-tolerated and useful in helping people with type 2 diabetes regulate their blood sugar, there have been more and more reports of people experiencing gastroparesis as a side effect of this drug. It is critical that patients and healthcare professionals are aware of this possible side effect of Trulicity and keep an eye out for any signs of gastroparesis. In these situations, prompt communication between patients and healthcare professionals is essential to guaranteeing the best possible care.